This agreement reinforces Credence’s role as a trusted partner to the pharmaceutical industry in advancing patient care. This ...
“Early personalization is often discussed as an enhancement rather than as a structural element of launch design,” said Emily ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
Incyte is asking viewers to imagine a drug ad that provokes more excitement than eye rolls. Attaching a self-deprecating opening to an Opzelura TV spot, the biotech serves up a typical pharma ad while ...
Cybin Inc. (the "Company") doing business as Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) ("Helus Pharma"), a clinical stage ...
The MarketWatch News Department was not involved in the creation of this content. Company expands leadership team as customer base grows and platform drives measurable commercial impact BOSTON, Nov.
Evoke Pharma, Inc. has appointed Greg Pyszczymuka to its Board of Directors as of February 20, 2025, marking the second addition to the board from Nantahala Capital Management, reflecting their ...
The pharmaceutical industry is experiencing a profound transformation in how it approaches commercial decision-making and insights delivery with a big wave of technology and AI at the doorstep. Market ...
Ascendis Pharma (ASND) announced that YORVIPATH is now commercially available by prescription in the United States. YORVIPATH is a prodrug of parathyroid hormone, administered once-daily, designed to ...
PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty ...
The company is developing innovative therapies for rare diseases like the exon-skipping therapy VILTEPSO®. PARAMUS, N.J., Nov. 26, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma) announced a change ...
Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...